Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Glucosamine Supplementation Not Likely to Raise HDL Levels
Link ID 1267
Title Glucosamine Supplementation Not Likely to Raise HDL Levels
Url http://www.medscape.com/viewarticle/566771?src=rss
Description Commonly consumed doses of glucosamine do not increase serum HDL cholesterol or its main component, apolipoprotein (apo) A1, in people with diabetes and low HDL cholesterol, researchers found in a small placebo-controlled crossover study. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date Dec 3, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Biomarkers May Help Identify Patients at Risk for Inflammatory Arthritis
  Serum cytokine profiles may be useful in guiding treatment decisions and prognosis. Medscape Medical News
Category:   Articles > Pharmacists


2. Financial Crisis to Increase Mental Health Woes: WHO
  The global financial crisis is likely to cause increased mental health problems and even suicides as people struggle to cope with poverty and unemployment, the World Health Organisation warned on Thursday. Reuters Health Information
Category:   Articles > Pharmacists


3. Etanercept Safe, Effective for Relapsing Refractory Polymyalgia Rheumatica
  The tumor necrosis factor (TNF) inhibitor etanercept is safe and appears to be a "useful corticosteroid-sparing agent in relapsing polymyalgia rheumatica (PMR)," according to a team of Italian investigators. Reuters Health Information
Category:   Articles > Pharmacists


4. Rofecoxib, Valdecoxib Linked to Increased Stroke Risk
  Rofecoxib (Vioxx) and valdecoxib (Bextra) are associated with an increased risk of stroke, according to results of a study published in the July issue of Stroke. Reuters Health Information
Category:   Articles > Pharmacists


5. FDA Grants Additional Indication for Rosuvastatin
  The Food and Drug Administration has approved a new indication for rosuvastatin to slow the progression of atherosclerosis in patients with elevated cholesterol. Medscape Medical News
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS